Attributes | Values |
---|
rdf:type
| |
description
| - videnskabelig artikel (da)
- article científic (ca)
- articolo scientifico (it)
- artigo científico (pt)
- bilimsel makale (tr)
- vedecký článok (sk)
- vetenskaplig artikel (sv)
- vědecký článek (cs)
- wetenschappelijk artikel (nl)
- wissenschaftlicher Artikel (de)
- научни чланак (sr)
- article scientifique (fr)
- artículu científicu espublizáu en 2007 (ast)
- наукова стаття, опублікована у вересні 2007 (uk)
- مقالة علمية نشرت في سبتمبر 2007 (ar)
- scientific article published on September 2007 (en)
|
publication date
| |
publication date
| |
language of work or name
| |
language of work or name
| |
cites work
| |
cites work
| |
author name string
| |
author name string
| |
rdfs:label
| - Cholinergic and other neurotransmitter mechanisms in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies. (en)
- Cholinergic and other neurotransmitter mechanisms in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies. (nl)
- Cholinergic and other neurotransmitter mechanisms in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies. (ast)
|
skos:prefLabel
| - Cholinergic and other neurotransmitter mechanisms in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies. (en)
- Cholinergic and other neurotransmitter mechanisms in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies. (nl)
- Cholinergic and other neurotransmitter mechanisms in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies. (ast)
|
name
| - Cholinergic and other neurotransmitter mechanisms in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies. (en)
- Cholinergic and other neurotransmitter mechanisms in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies. (nl)
- Cholinergic and other neurotransmitter mechanisms in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies. (ast)
|
author
| |
author
| |
title
| |
title
| - Cholinergic and other neurotransmitter mechanisms in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies (en)
|
page(s)
| |
page(s)
| |
instance of
| |
instance of
| |
main subject
| |
main subject
| |
PubMed ID
| |
PubMed ID
| |
PubMed ID
| |
published in
| |
published in
| |
volume
| |
volume
| |
DOI
| |
DOI
| |
DOI
| |
is about
of | |
is cites work
of | - Hallucinations in Parkinson disease
- The epigenetics of aging and neurodegeneration.
- Functions of the nigrostriatal dopaminergic synapse and the use of neurotransplantation in Parkinson's disease
- A clinico-pathological study of subtypes in Parkinson's disease
- Commentary: DLB and PDD: the same or different? Is there a debate?
- Psychosis in Parkinson's disease: phenomenology, frequency, risk factors, and current understanding of pathophysiologic mechanisms.
- Evidence for gender-specific transcriptional profiles of nigral dopamine neurons in Parkinson disease
- Neuropathology of sporadic Parkinson's disease: evaluation and changes of concepts
- The Progressive BSSG Rat Model of Parkinson's: Recapitulating Multiple Key Features of the Human Disease
- Neuropsychiatric symptoms in patients with dementias associated with cortical Lewy bodies: pathophysiology, clinical features, and pharmacological management.
- Early Parkinson's disease: longitudinal changes in brain activity during sequence learning
- Pharmacophore generation, atom-based 3D-QSAR, HQSAR and activity cliff analyses of benzothiazine and deazaxanthine derivatives as dual A2A antagonists/MAO‑B inhibitors.
- An update expert opinion on management and research strategies in Parkinson's disease psychosis
- Visual hallucinations in the differential diagnosis of parkinsonism
- Neurobiology of cognitive impairment in Parkinson's disease
- Cholinergic connectivity: it's implications for psychiatric disorders.
- The clinical characteristics of dementia with Lewy bodies and a consideration of prodromal diagnosis
- Cerebral correlates of psychotic syndromes in neurodegenerative diseases
- A Risk-Benefit Assessment of Dementia Medications: Systematic Review of the Evidence
- Disease-associated differences in religious cognition in patients with Parkinson's disease
- Pedunculopontine cholinergic cell loss in hallucinating Parkinson disease patients but not in dementia with Lewy bodies patients.
- Advances in the treatment of cognitive impairment in Parkinson's disease
- Pharmacogenetic regulation of acetylcholinesterase activity in Drosophila reveals the regulatory mechanisms of AChE inhibitors in synaptic plasticity
- Effect of cognitive fluctuation on neuropsychological performance in aging and dementia
- Microfabricated Probes for Studying Brain Chemistry: A Review.
- An iTRAQ-based proteomic analysis reveals dysregulation of neocortical synaptopodin in Lewy body dementias
- Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.
- Are dementia with Lewy bodies and Parkinson's disease dementia the same disease?
- What Is the Link Between Hallucinations, Dreams, and Hypnagogic-Hypnopompic Experiences?
- Electroencephalographic prodromal markers of dementia across conscious states in Parkinson's disease
- EEG Characteristics of Dementia With Lewy Bodies, Alzheimer's Disease and Mixed Pathology
- Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update-I. Hypokinetic-rigid movement disorders
- Association cortex hypoperfusion in mild dementia with Lewy bodies: a potential indicator of cholinergic dysfunction?
|